Shuttle Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $5 |
Gross Profit | -1 | -1 | -1 | |
EBITDA | -2,327 | -3,910 | -3,040 | -1,437 |
EBIT | -2,328 | -3,910 | -3,041 | -1,439 |
Net Income | -2,347 | -3,706 | -3,053 | -1,598 |
Net Change In Cash | 0 | 0 | 0 | 5 |
Free Cash Flow | -2,626 | -3,355 | -2,526 | -2,690 |
Cash | 2,094 | 4,817 | 4,512 | 1,920 |
Basic Shares | 2,233 | 1,126 | 4,076 | 4,076 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -5 | -6 | -5 | -60 |
EBITDA | -7,779 | -3,990 | -4,319 | -1,040 |
EBIT | -7,784 | -3,997 | -4,325 | -1,101 |
Net Income | -9,144 | -6,592 | -4,996 | -1,152 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,327 | -5,600 | -2,710 | -300 |
Cash | 1,920 | 2,576 | 8,417 | 504 |
Basic Shares | 10,324 | 15,906 | 10,351 | 13,586 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$1.05 |
2025-06-30 | -$3.29 |
2025-03-31 | -$7.60 |
2024-12-31 | -$0.40 |
